Synthesis and Crystal Structure of 2-p-Methyloxyphenyl- 3a-（2-phenyl-1,2,3-triazole-4-yl）-3,4-dihydro-1,2,4- oxa-diazolo[4,5-d][1,5] Benzothiazepine

The title compound2-p-methyloxyphenyl-3a-(2-phenyl-1,2,3-triazole-4-yl)-3,4- dihydro-1,2,4-oxa-diazolo[4,5-d][1,5] benzothiazepine (C31H25N5O2S, Mr = 531.63) has been syn- thesized and its structure was determined by single-crystal X-ray diffraction. The crystal belongs to triclinic, space group P1 with a = 10.888(2), b = 15.115(3), c = 16.702(3), α = 99.90(3), β = 95.21(3), γ = 100.41(3)o, V = 2642.1(9) nm3, Dc = 1.336 g/cm3, Z = 4, F(000) = 1112, μ = 0.162 mm-1 ,λ(MoKα) = 0.071073 nm, R = 0.0357 and wR = 0.1126 for 10620 observed reflections with I > 2σ(I). X-ray analysis reveals that the molecular backbone consists of a tricyclic system with the central seven- membered ring in a twisted boat-like conformation.     

New liquid crystals derived from thiophene connected to the 1,2,4-oxadiazole heterocycle

In this study, eight new compounds derived from thiophene were synthesised and characterised. The four symmetrical compounds contain two heterocyclic 1,2,4- oxadiazole on each side of the 2,5-disubstituted thiophene, and the four non-symmetrical compounds contain alkyne groups as a spacer replacing one of these heterocycles. Some of the compounds presented liquid crystalline properties with smectic and nematic mesophases. The non-symmetrical compounds presented low emission of blue light.     

含有异噁唑的S-三唑[3,4-b]-1,3,4-噻二嗪、咪唑[2,1-b]-1,3,4-噻二唑和咪唑[2,1-b]-1,3,4-噁二唑衍生物的合成

异噁唑衍生物作为一类重要的生物活性物质,其合成一直受到人们的关注,其中德国HMR公司开发研制的新型抗内风湿性关节炎药来氟米特(Leftunomide)已于1998年在美国率先上市,该药还具有很好的免疫调节作用．7H-均三唑[3,4-b]-1,3,4-噻二嗪、咪唑并[2,1-b]噻唑和咪唑并[2,1-b]-1,3,4-噻二唑衍生物均表现出广谱的生物活性．     

Manganese oxide nanoparticles supported on graphene oxide as an efficient nanocatalyst for the synthesis of 1,2,4-oxadiazoles from aldehydes

The easy synthesis of graphene oxide (GO)-supported manganese dioxide (MnO₂) nanoparticles as a stable heterogeneous nanocatalyst (MnO₂@GO) is described. This catalyst was investigated in the synthesis of 1,2,4-oxadiazoles from amidoximes and aldehydes via a cyclization and oxidation process. The nanocomposite was prepared and characterized using various techniques. The catalytic application of the nanocomposite was examined in the reaction of a variety of aldehydes with aliphatic and aromatic amidoximes. The stable and robust catalyst was recycled for seven consecutive runs without a significant decrease in the catalytic activity.     

Design and synthesis of 3,5-disubstituted boron-containing 1,2,4-oxadiazoles as potential combretastatin A-4 (CA-4) analogs

We have designed and synthesized a small library of 3,5-disubstituted-1,2,4-oxadiazole containing combretastatin A-4 (CA-4) analogs. Our objective is to increase the efficacy of the CA-4 as an anti-tubulin and antimitotic agent by substituting the cis-alkene bond with one of its bioisosteres, the 1,2,4-oxadiazole ring. We also modified the substituents attached to both of the phenyl rings (ring A and B in Fig. 1) of CA-4 for the purpose of diversifying our analogs based on SAR. These compounds were synthesized via a coupling reaction between an amidoxime and a carboxylic acid in DMF solvent, with HOBt as a base, and utilizing EDCI as a coupling reagent. Using this protocol, we synthesized a small library of 10 compounds with moderate to good yields. A detailed biological study is currently undergoing in our laboratory to evaluate the activity of these compounds.     

2-取代氨基-5-去氢枞基-1,3,4-噁二唑衍生物的合成及除草活性

以去氢枞酸为原料,经酰化后与水合肼反应合成去氢枞酰肼3,再与芳基异硫氰酸酯反应,得到中间体1-去氢枞酰基-4-取代基氨基硫脲4,4在Hg(OAc)2/EtOH条件下关环,合成得到一系列新型2-取代氨基-5-去氢枞基-1,3,4-噁二唑化合物5.采用IR,MS,1HNMR,13C NMR和元素分析等方法对中间体4和目标产物5进行了分析和表征.初步的除草活性测试表明,化合物4和5对油菜的胚根生长以及对稗草的幼苗生长有一定的抑制作用,其中化合物4d在浓度为100mg/L时对油菜胚根生长的抑制率达88.2％.     

微波促进下1-芳甲酰基-4-(2′-苯并呋喃甲酰基)氨基硫脲及其衍生物的合成

微波辐射条件下 ,首先由 2 苯并呋喃甲酰氯在相转移条件下依次与硫氰酸铵和芳甲酰肼反应合成了一系列 1 芳甲酰基 4 ( 2′ 苯并呋喃甲酰基 )氨基硫脲 .进一步在微波辐射的条件下由这些氨基硫脲分别与碘酸钾、醋酸或醋酸汞等试剂作用高产率地制得了 1 芳甲酰基 4 ( 2′ 苯并呋喃甲酰基 )氨基脲、2 芳基 5 ( 2′ 苯并呋喃甲酰胺基 ) 1,3 ,4 噻二唑和 2 芳基 5 ( 2′ 苯并呋喃甲酰胺基 ) 1,3 ,4 二唑 .     

1,3,4-噁二唑和1,3,4-噻二唑衍生物的设计、合成和生物活性研究

为了寻求新型抗肿瘤药物,设计并合成了一系列新型1,3,4-噁二唑和1,3,4-噻二唑衍生物,对这些化合物在人类四种癌细胞:B-16(皮肤黑色素瘤细胞)、PC-3(人前列腺癌细胞)、U87(人原发性胶质母细胞瘤细胞)和A549(人非小细胞肺癌细胞)进行抗肿瘤活性评价.结果显示部分化合物具有较好的抗肿瘤活性,尤其是5-{6-[4-(2-羟基乙基)哌嗪-1-基]-2-甲基嘧啶-4-基氨基}-[1,3,4-噻二唑-2-羧酸(2-甲氧基苯基)酰胺(8b)]和5-{6-[4-(2-羟基乙基)哌嗪-1-基]-2-甲基嘧啶-4-基氨基}-[1,3,4-噻二唑-2-羧酸(4-甲氧基苯基)酰胺(8c)],对四种癌细胞都显示出较高的抗肿瘤活性,其抑制活性均优于阳性对照达沙替尼,随后对这类化合物抑制肿瘤的可能靶点开展了进一步研究.